Stay updated on IBI310 and Siltilimab in NPC Clinical Trial

Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2 (from v3.0.1); the Back to Top element was removed. No changes to core content, pricing, stock, or time-slot data.
    Difference
    0.8%
    Check dated 2025-09-14T23:24:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.8%
    Check dated 2025-09-07T20:07:07.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-31T12:53:10.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T05:20:23.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T01:01:46.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T19:51:13.000Z thumbnail image

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.